We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZEO:NASDAQZeo Energy Corporation Analysis

Data as of 2026-05-12 - not real-time

$0.92

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Zeo Energy Corp. (ZEO) trades at $0.92, comfortably above its 20‑day (≈$0.87) and 50‑day (≈$0.83) simple moving averages but still below the 200‑day SMA (≈$1.28), indicating short‑term momentum in a longer‑term downtrend. The RSI sits at 55, suggesting neutral price pressure, while a bullish MACD crossover (+0.003) provides a modest technical upside bias. The stock is perched between a clear support zone at $0.56 and resistance near $1.12, with recent volume trending lower, hinting at waning participation. Volatility is extreme, with a 30‑day swing of roughly 119% and a computed beta near 1.9, exposing the equity to amplified market moves. Fundamentally, the company is distressed: revenue has slipped 0.4%, operating margin is –22.7%, and both operating and free cash flow are deeply negative. The balance sheet shows a debt‑to‑equity ratio of nearly 3× and a negative book value per share (‑$0.055), resulting in a nonsensical price‑to‑book of –16.8. Despite a modest price‑to‑sales of 1.6, the lack of earnings (PE = 0) and zero dividend underscore cash‑flow strain. The “Extreme Greed” market sentiment (Fear & Greed Index 88) may be inflating price expectations despite these weaknesses. Overall, the technical setup offers a thin upside window, but the underlying financial health and high volatility present significant downside risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price above short‑term SMAs but below long‑term SMA
  • Bullish MACD but decreasing volume
  • Support level provides downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Negative margins and cash flow limit upside
  • High debt‑to‑equity ratio raises solvency concerns
  • Sector volatility and regulatory exposure

Long Term

> 3 years
Cautious
Model confidence: 3/10

Key Factors

  • Sustained operating losses and negative free cash flow
  • Negative book value and unrealistic price‑to‑book ratio
  • Elevated beta and historical max drawdown of >84%

Key Metrics & Analysis

Financial Health

Revenue Growth-0.40%
Profit Margin-20.20%
ROE-43.43%
ROA-21.77%
Debt/Equity2.99
P/B Ratio-16.8
Op. Cash Flow$-8691421
Free Cash Flow$-6161290
Industry P/E39.0

Technical Analysis

TrendNeutral
RSI54.8
Support$0.56
Resistance$1.12
MA 20$0.87
MA 50$0.83
MA 200$1.28
MACDBullish
VolumeDecreasing
Fear & Greed Index87.98

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.89
Volatility118.95%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.